Co-op does not currently operate. It is the first acquisition by Ventures and a clear statement of intent to develop new and innovative customer solutions in the health sector.
The healthcare sector is a natural fit for The Co-op. It’s an area the Co-op has previous experience in, aligns well with The Co-op’s existing business areas in Food, Insurance and later life and is also an area which will appeal to its 4.6 million members, given the strength of the brand.
The acquisition will enable The Co-op to compete effectively within the £10.5 billion pharmacy market, where over 1.1 billion prescriptions are written annually in England alone. Already 29 million people in the UK receive a regular repeat prescription and this number is forecast to grow significantly in the years ahead, driven by an ageing population and access to effective medicines.
As part of the transaction, the co-founders of Dimec will continue working with the Co-op Ventures team. In addition, a number of new jobs will be created in digital, operational and clinical roles.
Dimec was founded by two pharmacists with a passion for using technology to make life easier for patients when it comes to managing and ordering repeat prescriptions. Over time, it has grown with other like-minded individuals who all share its core values; putting patients at the centre of everything it does.
On 5 November the “Cooperative Vision for a Sustainable and Competitive Europe:...
We are excited to invite you to our upcoming event, “Cooperative Vision for a Sustainable...
The European Court of Auditors has recently issued a significant warning regarding the...
On 7 November, the Euro Coop board meeting in Turin provided delegates with a chance to...
The United Nations has officially launched the logo for the 2025 International Year of...
Coop Group in Czech Republic has been recognized for its forward-thinking digital innovation at...